title: Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae.
abstract: Although the absorption, transport, and catabolism of dietary lipids have been studied extensively in great detail in mammals and other vertebrates, a tractable genetic system for identifying novel genes involved in these physiologic processes is not available. To establish such a model, we monitored neutral lipid by staining fixed zebrafish larvae with oil red o (ORO). The head structures, heart, vasculature, and swim bladder stained with ORO until the yolk was consumed 6 days after fertilization (6 dpf). Thereafter, the heart and vasculature no longer had stainable neutral lipids. Following a high-fat meal, ORO stained the intestine and vasculature of 6 dpf larvae, and whole-larval triacylglycerol (TAG) and apolipoprotein B levels increased. Levels of microsomal triglyceride transfer protein (Mtp), the protein responsible for packaging TAG and betalipoproteins into lipoprotein particles, were unchanged by feeding. Since the developing zebrafish embryo expresses mtp in the yolk cell layer, liver, and intestine, we determined the effect of targeted knockdown of Mtp expression using an antisense morpholino oligonucleotide approach (Mtp MO) on the transport of yolk and dietary lipids. Mtp MO injection led to loss of Mtp expression and of lipid staining in the vasculature, heart, and head structures. Mtp MO-injected larvae were smaller than age-matched, uninjected larvae, consumed very little yolk, and did not absorb dietary neutral lipids; however, they absorbed a short chain fatty acid that does not require Mtp for transport. Importantly, the vasculature appeared unaffected in Mtp MO-injected larvae. These studies indicate that zebrafish larvae are suitable for genetic studies of lipid transport and metabolism.
authors.affiliation: Department of Biochemistry and Biophysics, University of California, MC-2711, 1550 Fourth Street, Room 381, San Francisco, California 94143, USA. amnon.schlegel@ucsf.edu
authors.forename: Amnon
authors.initials: A
authors.lastname: Schlegel
authors.forename: Didier Y R
authors.initials: DY
authors.lastname: Stainier
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D002352:Carrier Proteins / Q000008:administration & dosage / Q000235:genetics / Q000502:physiology*; D045744:Cell Line, Tumor; D004041:Dietary Fats / Q000378:metabolism*; D004530:Egg Yolk / Q000378:metabolism*; D006801:Humans; D007408:Intestinal Absorption / Q000235:genetics / Q000502:physiology; D007814:Larva / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D050356:Lipid Metabolism / Q000235:genetics; D008077:Lipoproteins, LDL / Q000378:metabolism; D008861:Microsomes / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism; D015027:Zebrafish / Q000235:genetics / Q000378:metabolism* / Q000502:physiology
chemical_list: D002352:Carrier Proteins; D004041:Dietary Fats; D008077:Lipoproteins, LDL; D014280:Triglycerides; C106092:microsomal triglyceride transfer protein